http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_293db84a6692dc02f5f22f27950ec660
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Flockhart |
| name | David A. Flockhart David A Flockhart |
| given-name | David A David A. |
| organization-name | Indiana University School of Medicine, Indianapolis, Indiana, USA. From the Laboratories for Pharmacogenetics, Genotyping Development, and Medical Informatics, RIKEN Center for Genomic Medicine, Yokohama; Department of Clinical Pharmacokinetics and Pharmacodynamics, School of Medicine, Keio University; Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo; Department of Surgery, Itoh Surgery and Breast Clinic; Department of Surgery, Yamakawa Breast Clinic, Kochi; First Department of Surgery, Sapporo Medical... From the Center for Clinical Epidemiology and Biostatistics (C.E.L., W.B.B., C.M.B., C.P.F., S.E. Kimmel, S.H.), Center for Pharmacoepidemiology Research and Training (C.E.L., W.B.B., D.A.F., C.P.F., S.E. Kimmel, S.H.), Department of Psychiatry (W.B.B.), Department of Neurology (S.E. Kasner), Division of Cardiovascular Medicine, Department of Medicine (S.E. Kimmel), and Department of Systems Pharmacology and Translational Therapeutics (S.H.), Perelman School of Medicine at the University of... Division of Clinical Pharmacology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana 46202, United States Department of Medicine, Indiana University, Indianapolis, IN, USA Division of Clinical Pharmacology, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN N. Lynn Henry, Jill Hayden, and Daniel F. Hayes, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; Faouzi Azzouz, Zereunesay Desta, Lang Li, Anne T. Nguyen, Suzanne Lemler, and David A. Flockhart, Indiana University School of Medicine; Anna Maria Storniolo, Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN; and Karineh Tarpinian, Elizabeth Yakim, and Vered Stearns, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD. Division of Clinical Pharmacology, Departments of Pharmacology and Internal Medicine, Georgetown University Medical Center, Washington, DC Division of Clinical Pharmacology, Department of Medicine, Indiana University School of Medicine, Indianapolis;Breast Oncology Program, University of Michigan, Ann Arbor, Mich;Breast Cancer Program, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, Md;Roche Molecular Diagnostics, Pleasanton, Calif. Indiana University, Indianapolis, Indiana, USA Laboratoire de Pharmacie Galenique et Biopharmacie, Universite de Rennes I, Rennes;Departments of Medicine, Psychiatry, and Pharmacology, Polymorphism Research Laboratory, and Center for Molecular Genetics, University of California at San Diego, VA San Diego Healthcare System, San Diego;Department of Medicine, Indiana University School of Medicine, Indianapolis, Ind, USA Division of Clinical Pharmacology, Department of Medicine, Indiana University School of Medicine, Indiana Institute for Personalized Medicine, Indianapolis, Indiana 46202, United States 1Indiana University School of Medicine, Indianapolis, Indiana. From the Divisions of Clinical Pharmacology (H.H., A.P., S.D.H., D.A.F., T.C.S.), Biostatistics (L.L., N.S.F.), and Endocrinology and Metabolism (U.W., M.H.W.), Department of Medicine, Indiana University School of Medicine, Indianapolis; and Division of Nephrology (P.C., D.T.O.), Department of Medicine, University of California San Diego School of Medicine. From the Division of Clinical Pharmacology, Georgetown University Medical Center, Washington, DC. d Division of Clinical Pharmacology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA From the Departments of Oncology, Biostatistics, Pathology, and Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine, Rochester, MN; Department of Medicine, Division of Hematology/Oncology; University of Michigan School of Medicine, Ann Arbor, MI; Department of Medicine, Division of Clinical Pharmacology, Indiana University, Bloomington, IN; and Department of Medicine, Division of Hematology and Oncology; Mayo Clinic Jacksonville, Jacksonville, FL. Authors' Affiliations: 1Division of Medical Oncology, 2Division of Clinical Pharmacology, Department of Molecular Pharmacology and Experimental Therapeutics, and 3Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota; 4Section of Cancer Genetics and Prevention and 5Department of Human Oncology, Allegheny General Hospital; 6National Surgical Adjuvant Breast and Bowel Project (NSABP), 7NSABP Biostatistical Center, 8Department of Biostatistics, Graduate School of Public Health, and 9Department of Medical Oncology, University of Pittsburgh, Pittsburgh, Pennsylvania; 10Indiana University, Indianapolis, Indiana; 11RIKEN Center for Genomic Medicine, Tokyo, Japan Department of Medicine, Division of Clinical Pharmacology Indiana University School of Medicine Indianapolis Indiana USA 8Division of Clinical Pharmacology, Department of Medicine, Indiana University, Indianapolis, Indiana; and Division of Clinical Pharmacology, Departments of Medicine and Pharmacology, Georgetown University Medical Center, Washington, D.C. Division of Clinical Pharmacology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA c Division of Clinical Pharmacology, Department of Medicine , Indiana University , Indianapolis, Indiana, USA David A Flockhart MD PhD, Division Director, Division of Clinical Pharmacology, Georgetown University Medical Center 1 School of Computing Science, Simon Fraser University, Burnaby, BC V5A 1S6, Canada, 2Department of Medicine, Division of Clinical Pharmacology, Indiana University School of Medicine, Indianapolis, IN 46202, USA and 3School of Informatics and Computing, Indiana University, Bloomington, IN 47401, USA Authors' Affiliations: Departments of 1Oncology, 2Molecular Pharmacology and Experimental Therapeutics, 3Health Sciences Research, Mayo Clinic, Rochester, Minnesota; 4Section of Cancer Genetics and Prevention, Allegheny General Hospital; 5National Surgical Adjuvant Breast and Bowel Project (NSABP); 6Department of Biostatistics, NSABP Biostatistical Center, Graduate School of Public Health, University of Pittsburgh; 7Department of Medical Oncology, University of Pittsburgh; 8Department of Human Oncology, Allegheny General Hospital, Pittsburgh, Pennsylvania; 9Indiana University, Indianapolis, Indiana; and 10RIKEN Center for Genomic Medicine, Tokyo, Japan Division of Clinical Pharmacology, Department of Medicine, School of Medicine; Indiana University; Indianapolis IN USA Department of Medicine Division of Clinical Pharmacology, Indiana University School of Medicine Indianapolis IN USA; Indiana Institute for Personalized Medicine Indianapolis IN USA Division of Clinical Pharmacology, Department of Medicine, Indiana University School of Medicine, 1001 West 10th Street, WD Myers Bldg., W7123, Indianapolis, IN 46202, USA. Division of Clinical Pharmacology, Indiana University School of Medicine, IN, USA Division of Clinical Pharmacology, Department of Medicine Indiana University School of Medicine Indianapolis Indiana From the Mayo Clinic, Rochester, MN; Massachusetts General Hospital Cancer Center, Harvard University, Boston, MA; RIKEN Center for Genomic Medicine, Tokyo, Japan; NCIC Clinical Trials Group, Kingston; Sunnybrook Odette Regional Cancer Centre, University of Toronto, Toronto, Ontario, Canada; Washington University, St Louis, MO; Indiana University, Indianapolis, IN; Johns Hopkins School of Medicine, Baltimore, MD; and Ohio State University Medical Center, Columbus, OH. William J. Irvin Jr, Christine M. Walko, Karen E. Weck, Joseph G. Ibrahim, Wing K. Chiu, E. Claire Dees, Howard L. McLeod, James P. Evans, Lisa A. Carey, University of North Carolina at Chapel Hill, Chapel Hill; Susan G. Moore, Oludamilola A. Olajide, Rex Hematology/Oncology Associates; Sean T. Canale, Carolina Breast Care Specialists, Raleigh; Mark L. Graham, Waverly Hematology/Oncology, Cary; Rachel E. Raab, East Carolina University, Greenville; Jeffrey M. Peppercorn, Duke University, Durham; Steven M.... Department of Pharmacology, Inje University College of Medicine and Clinical Pharmacology Center, Pusan Paik Hospital, Pusan, Korea;Department of Pharmacology, Inha University College of Medicine, Inchon, Korea;Department of Pharmacology, Seoul National University College of Medicine, Seoul, Korea;Division of Clinical Pharmacology, Georgetown University Medical Center, Washington, DC Indiana University Bloomington IN 47405 USA b Division of Clinical Pharmacology, Indiana University School of Medicine, Indianapolis, Indiana, USA Authors' Affiliations: 1Division of Medical Oncology, 2Department of Health Sciences Research, and 3Division of Clinical Pharmacology, Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota; 4Department of Breast Oncology, M.D. Anderson Cancer Center, Houston, Texas; 5Breast Medicine Service, Memorial Sloan Kettering Cancer Center, New York, New York; 6Division of Hematology/Oncology, Mayo Clinic, Scottsdale, Arizona; 7Division of Hematology/Oncology, Mayo Clinic, Jacksonville, Florida; 8Division of Clinical Pharmacology, Indiana University School of Medicine, Indianapolis, Indiana; and 9Taylor Technology, Inc., Princeton, New Jersey Division of Clinical Pharmacology, Indiana University, School of Medicine, Indianapolis, IN, USA From the Division of Clinical Pharmacology, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN; Breast Oncology Program, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; and Breast Cancer Program, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD |
Incoming Links
Total number of triples: 221.